Effect of FK480, a CCK-A receptor antagonist, on spontaneously developed chronic pancreatitis in WBN/Kob rats

Pancreas

Volumn 17, Issue 3, 1998, Pages 295-300

  Ito, Harunobu ^a   Sogabe, Hajime ^a   Kuno, Masako ^a   Satoh, Yoshinari ^a   Ogawa, Toshikazu ^a   Konishi, Kayo ^a   Yoshida, Keizo ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Cholecystokinin A receptor antagonist; Chronic pancreatitis; FK480; WBN Kob rats

Indexed keywords

AMYLASE; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ A RECEPTOR ANTAGONIST; MACROGOL 400; N [1 (2 FLUOROPHENYL) 3,4,6,7 TETRAHYDRO 4 OXOPYRROLO[3,2,1 JK][1,4]BENZODIAZEPIN 3 YL] 1H INDOLE 2 CARBOXAMIDE;

AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHRONIC PANCREATITIS; CONTROLLED STUDY; DRUG EFFECT; FIBROSIS; HISTOLOGY; INFLAMMATORY CELL; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; ORGAN WEIGHT; PRIORITY JOURNAL; RAT;

EID: 0031662349     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199810000-00012     Document Type: Article

References (19)

1. Kobori O, Gedigk P, Totovic V. Adenomatous changes and adenocarcinoma of glandular stomach in Wistar rats induced by N-methyl-N′-nitro-N-nitrosoguanidine. Virchows Arch [A] 1977;373: 37-54.
2. Tsuchitani M, Saegusa T, Narama I, Nishikawa T, Gonda T. A new diabetic strain of rat (WBN/Kob). Lab Anim 1985;19:200-7.
3. Nakama K, Shichinohe K, Kobayashi K, et al. Spontaneous diabetes-like syndrome in WBN/Kob rats. Acta Diabetol Lat 1985; 22:335-12.
4. Ishizaki M, Masuda Y, Fukuda Y, et al. Renal lesion in a strain of spontaneously diabetic WBN/Kob rats. Acta Diabetol Lat 1987; 24:27-35.
5. Ohashi K, Kim J-H, Hara H, et al. WBN/Kob rats. A new spontaneously occurring model of chronic pancreatitis. Int J Pancreatol 1990;6:231-47.
6. Satoh Y, Matsuo T, Sogabe H, et al. Studies on a novel, potent and orally effective cholecystokinin-A antagonist, FK480. Synthesis and structure-activity relationships of FK480 and related compounds. Chem Pharm Bull 1994;42:2071-83.
7. Ito H, Sogabe H, Nakarai T, et al. Pharmacological profile of FK480, a novel cholecystokinin type-A receptor antagonist; comparison to loxiglumide. J Pharmacol Exp Ther 1994;268:571-5.
8. Tachibana I, Otsuki M. Effects of a benzodiazepine derivative-cholecystokinin receptor antagonist FK480 on pancreatic exocrine secretion in anesthetized rats. Dig Dis Sci 1996;39:1321-8.
9. Tani S, Okabayashi Y, Nakamura T, Fujii M, Itoh H, Otsuki M. Effect of a new cholecystokinin receptor antagonist loxiglumide on acute pancreatitis in two experimental animal models. Pancreas 1990;5:284-90.
10. Tani S, Itoh H, Koide M, Okabayashi Y, Otsuki M. Involvement of endogenous cholecystokinin in the development of acute pancreatitis induced by closed duodenal loop. Pancreas 1993;8:109-15.
11. Majumdar APN, Vesenka GD, Dubick MA. Acceleration of pancreatic regeneration by cholecystokinin in rats. Pancreas 1987;2: 199-204.
12. Jurkowska G, Grondin G, Morisset J. Involvement of endogenous cholecystokinin in pancreatic regeneration after cerulein-induced acute pancreatitis. Pancreas 1992;7:295-304.
13. Lampel M, Kern HF. Acute interstitial pancreatitis in the rat induced by excessive dose of a pancreatic secretagogue. Virchows Arch [A] 1977;373:97-117.
14. Ito H, Sogabe H, Satoh Y. CCK-A receptor antagonists. Drugs Fut 1995;20:587-99.
15. Sugiyama M, Kobori O, Atomi Y, Wada N, Kuroda A, Muto T. Effect of oral administration of protease inhibitor on pancreatic exocrine function in WBN/Kob rats with chronic pancreatitis. Pancreas 1996;13:71-9.
16. Shimoda I, Koizumi M, Shimosegawa T, et al. Physiological characteristics of spontaneously developed diabetes in male WBN/Kob rat and prevention of development of diabetes by chronic oral administration of synthetic trypsin inhibitor (FOY-305). Pancreas 1993;8:196-203.
17. Nakano S, Tachibana I, Otsuki M. Effect of cholecystokinin receptor antagonist loxiglumide on pancreatic exocrine function in rats after acute pancreatitis. Pancreas 1995;10:287-94.
18. Okumura Y, Inoue H, Fujiyama Y, Bamba T. Effects of short-term administration of the CCK receptor antagonist, KSG-504, on regeneration of pancreatic acinar cells in acute pancreatitis in rats. J Gastroenterol 1995;30:493-9.
19. Funakoshi A, Nakano I, Shinozaki H, Tateishi K, Hamaoka T, Ibayashi H. High plasma cholecystokinin levels in patients with chronic pancreatitis having abdominal pain. Am J Gastroenterol 1986;81:1174-8.